表紙
市場調査レポート

未分化甲状腺癌:世界の治験動向

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 328410
出版日 ページ情報 英文 80 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
未分化甲状腺癌:世界の治験動向 Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015
出版日: 2015年02月27日 ページ情報: 英文 80 Pages
概要

当レポートでは、世界の未分化甲状腺癌治療薬の臨床試験について調査し、地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断 (一時中止、廃止、打ち切り) された試験のリストなどを提供しています。

イントロダクション

  • 未分化甲状腺癌
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:癌治療薬の治験における未分化甲状腺癌の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:癌治療薬の治験における未分化甲状腺癌の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

未分化甲状腺癌治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • OXiGENE, Inc.
    • Bayer AG
    • エーザイ
    • 第一三共
    • GlaxoSmithKline plc
    • Genelux Corporation
  • 代表的な研究機関・病院の治験の概要
    • National Cancer Institute
    • Case Comprehensive Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino
    • University of Schleswig-Holstein
    • University of Colorado
    • University of Michigan Comprehensive Cancer Center
    • University of Kentucky
    • Leiden University Medical Center

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2582CTIDB

GlobalData's clinical trial report, "Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Anaplastic Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Anaplastic Thyroid Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Anaplastic Thyroid Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Anaplastic Thyroid Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • OXiGENE, Inc.
      • Clinical Trial Overview of OXiGENE, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Genelux Corporation
      • Clinical Trial Overview of Genelux Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino
      • Clinical Trial Overview of Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino
      • University of Schleswig-Holstein
      • Clinical Trial Overview of University of Schleswig-Holstein
      • University of Colorado
      • Clinical Trial Overview of University of Colorado
      • University of Michigan Comprehensive Cancer Center
      • Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
      • University of Kentucky
      • Clinical Trial Overview of University of Kentucky
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OXiGENE, Inc., 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genelux Corporation, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*

List of Figures

  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top